Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin

Reactivating the fetal globin gene Mutation of adult-type globin genes causes sickle cell disease and thalassemia. Although treating these hemoglobinopathies with gene therapy is possible, there is a pressing need for pharmacologic approaches to treat general patient populations. One promising approach is to reactivate repressed expression of fetal-type hemoglobin (HbF) in adult erythroid cells. Masuda et al. reveal a molecular mechanism governing HbF repression as mediated by the LRF/ZBTB7A transcription factor. The study may encourage the development of new HbF reactivation therapies for hemoglobinopathies. Science, this issue p. 285 Reactivation of fetal globin gene expression may enable treatment of hemoglobinopathies. Genes encoding human β-type globin undergo a developmental switch from embryonic to fetal to adult-type expression. Mutations in the adult form cause inherited hemoglobinopathies or globin disorders, including sickle cell disease and thalassemia. Some experimental results have suggested that these diseases could be treated by induction of fetal-type hemoglobin (HbF). However, the mechanisms that repress HbF in adults remain unclear. We found that the LRF/ZBTB7A transcription factor occupies fetal γ-globin genes and maintains the nucleosome density necessary for γ-globin gene silencing in adults, and that LRF confers its repressive activity through a NuRD repressor complex independent of the fetal globin repressor BCL11A. Our study may provide additional opportunities for therapeutic targeting in the treatment of hemoglobinopathies.

[1]  S. Tsuzuki,et al.  The LRF transcription factor regulates mature B cell development and the germinal center response in mice. , 2011, The Journal of clinical investigation.

[2]  Morgan C. Giddings,et al.  Defining functional DNA elements in the human genome , 2014, Proceedings of the National Academy of Sciences.

[3]  M. Mann,et al.  In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.

[4]  J. Kutok,et al.  Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. , 2004, The Journal of clinical investigation.

[5]  K. Gaensler,et al.  Methyl binding domain protein 2 mediates γ-globin gene silencing in adult human βYAC transgenic mice , 2006 .

[6]  Matthew C. Canver,et al.  Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells*♦ , 2014, The Journal of Biological Chemistry.

[7]  T. Ley,et al.  An enhancer element lies 3′ to the human A gamma globin gene. , 1987, The EMBO journal.

[8]  Yukio Nakamura,et al.  Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells , 2012, PloS one.

[9]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[10]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[11]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[12]  Erik Splinter,et al.  Looping and interaction between hypersensitive sites in the active beta-globin locus. , 2002, Molecular cell.

[13]  L. Schomburg,et al.  Molecular characterization of a puromycin‐insensitive leucyl‐specific aminopeptidase, PILS‐AP , 2000, European journal of biochemistry.

[14]  G. Stamatoyannopoulos,et al.  Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human beta-globin locus display proper developmental control of human globin genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Charles Elkan,et al.  Fitting a Mixture Model By Expectation Maximization To Discover Motifs In Biopolymer , 1994, ISMB.

[16]  Matthew C. Canver,et al.  BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis , 2015, Nature.

[17]  Sung-Uk Lee,et al.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function , 2012, Immunological reviews.

[18]  A. Melnick,et al.  Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer. , 2008, Molecular cell.

[19]  Elhanan Borenstein,et al.  Conservation of trans-acting circuitry during mammalian regulatory evolution , 2014, Nature.

[20]  Timothy L. Bailey,et al.  Gene expression Advance Access publication May 4, 2011 DREME: motif discovery in transcription factor ChIP-seq data , 2011 .

[21]  David J. Arenillas,et al.  JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles , 2013, Nucleic Acids Res..

[22]  J. Licht,et al.  Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells , 2004, Nature Medicine.

[23]  Daniel E Bauer,et al.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders. , 2012, Blood.

[24]  Alexander D. MacKerell,et al.  A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. , 2010, Cancer cell.

[25]  B. Haynes,et al.  Elevation of Intact and Proteolytic Fragments of Acute Phase Proteins Constitutes the Earliest Systemic Antiviral Response in HIV-1 Infection , 2010, PLoS pathogens.

[26]  L. Hersh,et al.  Puromycin-sensitive Aminopeptidase , 1995, The Journal of Biological Chemistry.

[27]  P. Pandolfi,et al.  Regulation of B Versus T Lymphoid Lineage Fate Decision by the Proto-Oncogene LRF , 2007, Science.

[28]  T. Bailey,et al.  Inferring direct DNA binding from ChIP-seq , 2012, Nucleic acids research.

[29]  Huidong Shi,et al.  MBD3 Localizes at Promoters, Gene Bodies and Enhancers of Active Genes , 2013, PLoS genetics.

[30]  Chunhui Hou,et al.  A positive role for NLI/Ldb1 in long-range beta-globin locus control region function. , 2007, Molecular cell.

[31]  M. Baron,et al.  The embryonic origins of erythropoiesis in mammals. , 2012, Blood.

[32]  Howard Y. Chang,et al.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.

[33]  Sebastian Herzog,et al.  BCL6 enables Ph+ acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition , 2011, Nature.

[34]  N. Mohandas,et al.  Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. , 2014, Blood.

[35]  G. Stamatoyannopoulos.  Control of globin gene expression during development and erythroid differentiation. , 2005, Experimental hematology.

[36]  P. Park,et al.  Design and analysis of ChIP-seq experiments for DNA-binding proteins , 2008, Nature Biotechnology.

[37]  G. Blobel,et al.  Role of the GATA-1/FOG-1/NuRD Pathway in the Expression of Human β-Like Globin Genes , 2010, Molecular and Cellular Biology.

[38]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[39]  Jeffrey Malik,et al.  Yolk sac-derived primitive erythroblasts enucleate during mammalian embryogenesis. , 2004, Blood.

[40]  P. Kingsley,et al.  "Maturational" globin switching in primary primitive erythroid cells. , 2005, Blood.

[41]  William Stafford Noble,et al.  Quantifying similarity between motifs , 2007, Genome Biology.

[42]  C. Chen,et al.  LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenance. , 2013, Blood.

[43]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[44]  F. Costantini,et al.  An embryonic pattern of expression of a human fetal globin gene in transgenic mice , 1986, Nature.

[45]  P. Pandolfi,et al.  LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. , 2009, Developmental cell.

[46]  David C Williams,et al.  Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells. , 2012, Blood.

[47]  Jacob C. Ulirsch,et al.  Altered Chromatin Occupancy of Master Regulators Underlies Evolutionary Divergence in the Transcriptional Landscape of Erythroid Differentiation , 2014, PLoS genetics.

[48]  Poshen B. Chen,et al.  Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells , 2011, Cell.

[49]  S. Hay,et al.  Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and Interventions , 2013, PLoS medicine.

[50]  J. Black.  Isoelectric focusing in agarose gel for detection and identification of hemoglobin variants. , 1984, Hemoglobin.

[51]  J. Hirschhorn,et al.  Supporting Online Material Materials and Methods Figs. S1 to S10 Tables S1 to S7 References Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-specific Repressor Bcl11a , 2022 .

[52]  P. Gregory,et al.  Controlling Long-Range Genomic Interactions at a Native Locus by Targeted Tethering of a Looping Factor , 2012, Cell.

[53]  S. Orkin,et al.  Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. , 2010, Genes & development.

[54]  Ross C Hardison,et al.  Identification of Biologically Relevant Enhancers in Human Erythroid Cells* , 2013, The Journal of Biological Chemistry.

[55]  F. Aguet,et al.  Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiology , 2015, Haematologica.

[56]  P. Linsley,et al.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application , 2010, Nature Reviews Drug Discovery.

[57]  P. Pandolfi,et al.  Role of the proto-oncogene Pokemon in cellular transformation and ARF repression , 2005, Nature.

[58]  Jie Li,et al.  Global transcriptome analyses of human and murine terminal erythroid differentiation. , 2014, Blood.

[59]  S. Orkin,et al.  Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A , 2013, Proceedings of the National Academy of Sciences.

[60]  Cong Peng,et al.  Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing , 2011, Science.

[61]  Stuart H. Orkin,et al.  Developmental and species-divergent globin switching are driven by BCL11A , 2009, Nature.

[62]  S. Pleasants.  Epidemiology: A moving target , 2014, Nature.